All Episodes
False Claims Act Insights — 42 episodes
Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More
Relators’ Attorneys’ Fees: Math, Limits, and How to Push Back
Healthcare Compensation and Referrals: Avoiding Compliance Pitfalls in Physician Deals
$1.6 Billion FCA Judgment on Appeal: What it Means for FCA Enforcement
Qui Tam Dismissals Are Spiking: What That Means for FCA Enforcement
DOJ Announces Record Number of Qui Tams and Qui Tam Dismissals
Rogue Employees: Vicarious Liability Under the False Claims Act
The Rise of State False Claims Act Enforcement
The Latest on Zafirov and the Future of Qui Tams
Understanding HIPAA Disclosures When Responding to CIDs in FCA Investigations
Recent Federal Executive Actions Place Anti-Discrimination Within the FCA’s Orbit
Be Careful What You Wish For: HHS-OIG Advisory Opinions
An FCA Perspective on Artificial Intelligence in the Healthcare Industry
Beyond Adversarialism: How to Steer FCA Investigations
The Mathematics of Nuclear FCA Verdicts
Bitter Pills: DOJ Targets Pharmacies for FCA Enforcement
Will Recent Leadership Changes Lead to FCA Enforcement Policy Changes?
How Payment Suspensions Can Impact FCA Litigation
Trump DOJ Sharpens Its Focus on Healthcare Fraud
DOJ’s Reliance on FCA to Pursue Covid-Related Fraud
Stranger Than Fiction? An FCA April Fools’ Day Episode
Emptying Our FCA Notebook: A Summary of Recent FCA-Related Developments
Can DE&I Initiatives Lead to Potential False Claims Act Liability?
Some FCA Whistles Are Louder Than Others
How Tariffs Can Increase Whistleblower Activity and Associated FCA Liability
Is DOJ Allowed to Share Privileged Documents with Whistleblowers in FCA Disputes?
Swamp Things: A Post-Election Look at DOJ’s False Claims Act Enforcement, Part II
Swamp Things: A Post-Election Look at DOJ’s False Claims Act Enforcement, Part I
How a Marine Fisheries Dispute Opened an FCA Can of Worms
Powerful, But Not All-Powerful: CIDs in FCA Litigation
Reality Checks: How to Approach Healthcare Transactions Without Triggering FCA Liability
Are the FCA’s Qui Tam Provisions Unconstitutional? One Federal Judge Says “Yes”
Are All Healthcare “Kickbacks” Subject to FCA Liability?
If Everything Matters, Nothing Does: Parsing Materiality in FCA Disputes
Assessing the Fallout from a Thermonuclear FCA Verdict
Eureka! Government Investigators Seek Out Research Misconduct
Physician, Refer Thyself: How Stark Law and FCA Intersect
The Art and Science of Corporate Compliance in Managing FCA Risk
Railroaded! How to Approach the Twin Tracks of Parallel Proceedings
Are We Done Here? The Unique Dynamics of FCA Settlements
Help! I Got a Civil Investigative Demand from DOJ. What Do I Do?
Think You Know Whistleblowers? Think Again.